EU consumers who use online resources to choose between different brand-name drugs are much more likely to advocate for themselves at the point-of-care. With this in mind, EU pharma marketers must think about what website features and content to provide for consumers that are going online to choose treatment options; this Strategic Insight covers what pharma marketers need to know.
Questions answered in this report:
How can pharma reach consumers choosing between different brand-name drugs?